Determining the Best Tool Comparable with Global Initiative for Asthma Criteria for Assessing Pediatric Asthma Control.

IF 1.1 4区 医学 Q4 ALLERGY
Pediatric Allergy Immunology and Pulmonology Pub Date : 2021-09-01 Epub Date: 2021-08-24 DOI:10.1089/ped.2020.1334
Ayşegül Akan, Emine Dibek Mısırlıoğlu, Ersoy Civelek, Can Naci Kocabaş
{"title":"Determining the Best Tool Comparable with Global Initiative for Asthma Criteria for Assessing Pediatric Asthma Control.","authors":"Ayşegül Akan,&nbsp;Emine Dibek Mısırlıoğlu,&nbsp;Ersoy Civelek,&nbsp;Can Naci Kocabaş","doi":"10.1089/ped.2020.1334","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Background:</i></b> Guidelines such as Global Initiative for Asthma (GINA) recommend disease control as the mainstay of asthma management. <b><i>Objective:</i></b> To investigate which measure of asthma control best correlates with the GINA criteria for determining asthma control in children. <b><i>Methods:</i></b> Child asthma-patients at a tertiary hospital were enrolled in the study after evaluation of response to treatment. Asthma control test (ACT)/pediatric asthma control test (PACT), Pediatric Asthma Quality of Life Questionnaire (PAQLQ), fractional exhaled nitric oxide (FeNO), and lung function parameters were evaluated. Patients were examined by asthma specialists and control status was evaluated based on GINA. <b><i>Results:</i></b> The median age (interquartile range) of patients was 10.7 (8.4-12.9) years, 57.9% of patients were boys. Of 228 children, 84.2%, 9.6%, and 6.1% displayed \"well-controlled\", \"partially controlled\", and \"uncontrolled\" asthma, respectively, according to GINA. The patients with \"partially controlled\" and \"uncontrolled\" asthma were grouped as \"not well-controlled.\" The cutoff levels were 22, 21, and 5.9 for PACT, ACT, and PAQLQ, respectively, for determining \"well-controlled\" asthma (<i>P</i> < 0.001). With these cutoff values, ACT exhibited higher comparability with GINA than PACT and PAQLQ (κ = 0.473, 0.221, and 0.150, respectively, <i>P</i> < 0.001). PAQLQ had higher agreement with GINA criteria in children ≥12 years old (κ = 0.326, <i>P</i> < 0.001 and κ = 0.151, <i>P</i> = 0.014, respectively). Correctly classified patients with PACT, ACT, and PALQLQ based on GINA with these cutoff levels were 93 (64.1%), 63 (75.9%), and 139 (62.9%), respectively. FeNO and lung function parameters were unsuccessful at revealing control status according to GINA. <b><i>Conclusion:</i></b> ACT is better than PACT for comparability with GINA. Better correlation of PAQLQ and ACT and better comparability of PAQLQ and GINA were evident in older children.</p>","PeriodicalId":54389,"journal":{"name":"Pediatric Allergy Immunology and Pulmonology","volume":null,"pages":null},"PeriodicalIF":1.1000,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664125/pdf/ped.2020.1334.pdf","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Allergy Immunology and Pulmonology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/ped.2020.1334","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/8/24 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 3

Abstract

Background: Guidelines such as Global Initiative for Asthma (GINA) recommend disease control as the mainstay of asthma management. Objective: To investigate which measure of asthma control best correlates with the GINA criteria for determining asthma control in children. Methods: Child asthma-patients at a tertiary hospital were enrolled in the study after evaluation of response to treatment. Asthma control test (ACT)/pediatric asthma control test (PACT), Pediatric Asthma Quality of Life Questionnaire (PAQLQ), fractional exhaled nitric oxide (FeNO), and lung function parameters were evaluated. Patients were examined by asthma specialists and control status was evaluated based on GINA. Results: The median age (interquartile range) of patients was 10.7 (8.4-12.9) years, 57.9% of patients were boys. Of 228 children, 84.2%, 9.6%, and 6.1% displayed "well-controlled", "partially controlled", and "uncontrolled" asthma, respectively, according to GINA. The patients with "partially controlled" and "uncontrolled" asthma were grouped as "not well-controlled." The cutoff levels were 22, 21, and 5.9 for PACT, ACT, and PAQLQ, respectively, for determining "well-controlled" asthma (P < 0.001). With these cutoff values, ACT exhibited higher comparability with GINA than PACT and PAQLQ (κ = 0.473, 0.221, and 0.150, respectively, P < 0.001). PAQLQ had higher agreement with GINA criteria in children ≥12 years old (κ = 0.326, P < 0.001 and κ = 0.151, P = 0.014, respectively). Correctly classified patients with PACT, ACT, and PALQLQ based on GINA with these cutoff levels were 93 (64.1%), 63 (75.9%), and 139 (62.9%), respectively. FeNO and lung function parameters were unsuccessful at revealing control status according to GINA. Conclusion: ACT is better than PACT for comparability with GINA. Better correlation of PAQLQ and ACT and better comparability of PAQLQ and GINA were evident in older children.

确定评估儿童哮喘控制与全球哮喘倡议标准的最佳工具。
背景:全球哮喘倡议(GINA)等指南建议将疾病控制作为哮喘管理的主要内容。目的:探讨确定儿童哮喘控制的GINA标准与哮喘控制的最佳相关性。方法:对某三级医院的儿童哮喘患者进行治疗效果评价,纳入研究。评估哮喘控制试验(ACT)/儿童哮喘控制试验(PACT)、儿童哮喘生活质量问卷(PAQLQ)、呼气一氧化氮分数(FeNO)和肺功能参数。患者由哮喘专家检查,并根据GINA评估控制状况。结果:患者中位年龄(四分位数间距)为10.7(8.4 ~ 12.9)岁,男孩占57.9%。在228名儿童中,84.2%、9.6%和6.1%分别表现出“良好控制”、“部分控制”和“未控制”的哮喘。“部分控制”和“未控制”的哮喘患者被归为“控制不好”。用于判定“控制良好”哮喘的PACT、ACT和PAQLQ的临界值分别为22、21和5.9 (P P P P分别= 0.014)。基于GINA正确分类PACT、ACT和PALQLQ患者,这些截止水平分别为93(64.1%)、63(75.9%)和139(62.9%)。根据GINA, FeNO和肺功能参数不能显示控制状态。结论:ACT与GINA的可比性优于PACT。PAQLQ与ACT有较好的相关性,PAQLQ与GINA有较好的可比性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.00
自引率
0.00%
发文量
23
审稿时长
>12 weeks
期刊介绍: Pediatric Allergy, Immunology, and Pulmonology is a peer-reviewed journal designed to promote understanding and advance the treatment of respiratory, allergic, and immunologic diseases in children. The Journal delivers original translational, clinical, and epidemiologic research on the most common chronic illnesses of children—asthma and allergies—as well as many less common and rare diseases. It emphasizes the developmental implications of the morphological, physiological, pharmacological, and sociological components of these problems, as well as the impact of disease processes on families. Pediatric Allergy, Immunology, and Pulmonology coverage includes: -Functional and genetic immune deficiencies- Interstitial lung diseases- Both common and rare respiratory, allergic, and immunologic diseases- Patient care- Patient education research- Public health policy- International health studies
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信